KiOmed Pharma - Crunchbase Company Profile & Funding

Q: Where is KiOmed Pharma's headquarters?

KiOmed Pharma is located in Herstal, Liege, Belgium.

Q: When was the last funding round for KiOmed Pharma?

KiOmed Pharma closed its last funding round on obfuscated from a Undisclosed round.

Q: How much funding has KiOmed Pharma raised to date?

KiOmed Pharma has raised obfuscated.

Overview

KiOmed Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About KiOmed Pharma

CB Rank

103728

KiOmed Pharma offers a unique pipeline of products to tackle invalidating OsteoArthritis, Skin Aging and Dry Eye syndrome.

Founded

obfuscation

Private

Funding Round

Herstal, Liege, Belgium

11-50

www.kiomedpharma.com/

Pharmaceutical

Funding Rounds

Funding Round

OBF

obfuscation

Key People

François Blondel: Executive Chairman of the Board, Founder

Details

Legal Name

KiOmed Pharma S.A.,

Operating Status

Active

Company Type

For Profit

Founders

François Blondel

Phone Number

+32 (0)4 228 80 40

Contact Email

contact@kiomedpharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

KiOmed Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

KioMedine vs one

An injectable medical device for symptomatic treatment of knee osteoarthritis, providing joint lubrication and reducing oxidative stress with a single injection.

KiOmedine® Technology Platform

A patented medical-grade carboxymethyl chitosan biopolymer used as a base for injectable and implantable medical devices with lubricating, antioxidative, and tissue-protective properties.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - KiOmed Pharma	—	obfuscated obfuscation	—	Funding Round